An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains
Open Access
- 10 February 2020
- journal article
- review article
- Published by MDPI AG in Journal of Fungi
- Vol. 6 (1) , 23
Abstract
Fungal infections and, in particular, those caused by species of the Candida genus, are growing at an alarming rate and have high associated rates of mortality and morbidity. These infections, generally referred as candidiasis, range from common superficial rushes caused by an overgrowth of the yeasts in mucosal surfaces to life-threatening disseminated mycoses. The success of currently used antifungal drugs to treat candidiasis is being endangered by the continuous emergence of resistant strains, specially among non-albicans Candida species. In this review article, the mechanisms of action of currently used antifungals, with emphasis on the mechanisms of resistance reported in clinical isolates, are reviewed. Novel approaches being taken to successfully inhibit growth of pathogenic Candida species, in particular those based on the exploration of natural or synthetic chemicals or on the activity of live probiotics, are also reviewed. It is expected that these novel approaches, either used alone or in combination with traditional antifungals, may contribute to foster the identification of novel anti-Candida therapies.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/BIO/04565/2013; UIDB/04565/2020; UID/QUI/00100/2013 and PTDC/BIA-MIC/31515/2017)
- Programa Operacional Regional de Lisboa 2020 (007317)
This publication has 183 references indexed in Scilit:
- The Microbiota of the Vagina and Its Influence on Women’s Health and DiseaseThe American Journal of the Medical Sciences, 2012
- Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicansAntimicrobial Agents and Chemotherapy, 2010
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin BAntimicrobial Agents and Chemotherapy, 2010
- Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal IsolatesAntimicrobial Agents and Chemotherapy, 2010
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- d -Glucan Synthase: Implication for the Existing Susceptibility BreakpointAntimicrobial Agents and Chemotherapy, 2009
- Formation of new chromosomes as a virulence mechanism in yeast Candida glabrataProceedings of the National Academy of Sciences, 2009
- Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strainsMolecular Microbiology, 2008
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2006
- Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicansScience, 2006